Summary
- Current Price
- As of today, SLN price is $11.24, up +0.63% on
- Current Price All-Time High
- SLN price is currently -67.89% below its historical high of $35.00 set on
- Market Cap
- SLN current market cap is $531M, up +100.36% over the past 365 days
- Revenue
- SLN current annual revenue is $560.30K, down -98.71% year-over-year
- Next Earnings
- The next earnings release for SLN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Silence Therapeutics plc |
| Ticker | NASDAQ: SLN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | silence-therapeutics.com |
| Employees | 116 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $11.24 | |
| Price, 1D Change | +0.63% | |
| $531M | ||
| - | ||
| - | ||
| 1.55 | ||
| $560K | ||
| Revenue, 1Y Change | -98.71% | |
| -$1.88 | ||
| EPS, 1Y Change | -91.87% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.88 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $560.30K | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $11.24 | |
| Price Target | - | $25.00 |
| Price Tgt. Change | - | +122.42% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.47 | - | |
| - | -$0.98 | - | |
| - | -$1.88 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $31.77M | - | |
| - | $43.28M | - | |
| - | $560.30K | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $11.24 | |
| $6.92 | ||
| $9.04 | ||
| $7.49 | ||
| $9.53 | ||
| $0.57 | ||
| 1.55 | ||
| $0.88 | ||
| 57.40 | ||
| 83.99% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $560.30K | ||
| -$1.88 | ||
| -$55.10K | ||
| -9.83% | ||
| -$82.48M | ||
| -14.72% | ||
| -$88.82M | ||
| -15.85% | ||
| -$81.93M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 8.72 | ||
| 8.72 | ||
| - | ||
| 3 | ||
| -2.49 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 631.97 | ||
| 10.75 | ||
| -6.48 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $62.30M | ||
| $85.11M | ||
| $131.44M | ||
| $118.66M | ||
| $69.14M | ||
| $13.61M | ||
| $160.00K | ||
| $89.00K | ||
| $4.41M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $89.38M | ||
| $82.43M | ||
| $615.40K | ||
| $0.00 | ||
| $556.30K | ||
| $0.00 | ||
| $11.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$62.42M | ||
| -$48.10M | ||
| $15.00K | ||
| $55.10K | ||
| -$62.47M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Morgan Stanley | → | |
| Goldman Sachs | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with SLN
FAQ
- What is the ticker symbol for Silence Therapeutics plc?
- The ticker symbol for Silence Therapeutics plc is NASDAQ:SLN
- Does Silence Therapeutics plc pay dividends?
- No, Silence Therapeutics plc does not pay dividends
- What sector is Silence Therapeutics plc in?
- Silence Therapeutics plc is in the Healthcare sector
- What industry is Silence Therapeutics plc in?
- Silence Therapeutics plc is in the Biotechnology industry
- What country is Silence Therapeutics plc based in?
- Silence Therapeutics plc is headquartered in United Kingdom
- When did Silence Therapeutics plc go public?
- Silence Therapeutics plc initial public offering (IPO) was on September 8, 2020
- Is Silence Therapeutics plc in the S&P 500?
- No, Silence Therapeutics plc is not included in the S&P 500 index
- Is Silence Therapeutics plc in the NASDAQ 100?
- No, Silence Therapeutics plc is not included in the NASDAQ 100 index
- Is Silence Therapeutics plc in the Dow Jones?
- No, Silence Therapeutics plc is not included in the Dow Jones index
- When was Silence Therapeutics plc last earnings report?
- Silence Therapeutics plc's most recent earnings report was on May 7, 2026
- When does Silence Therapeutics plc report earnings?
- The next expected earnings date for Silence Therapeutics plc is August 6, 2026
Data Sources & References
- SLN Official Website www.silence-therapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1479615/000119312526092591/0001193125-26-092591-index.htm
- SLN Profile on Yahoo Finance finance.yahoo.com/quote/SLN
- SLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sln